Developer of in-vitro diagnostic testing kits. The company focuses on the R&D, production, sales, and testing services of individualized molecular diagnostic reagents. The company provides accurate detection of genes and antigens for patients with hematological diseases, solid tumors, and infectious diseases. The main products are leukemia-associated fusion gene detection kit, immunoglobulin gene rearrangement detection kit, human EGFR gene mutation detection kit, etc. Founded in 2014, headquart The company operates in Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools. Its business models include Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification, Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis. Founded in 2014. Headquartered in China, Shaoyang. The company has raised funding at the Series B stage. Backed by investors including ShenZhen GTJA Investment Group, CD Capital, Cathay Capital, Linkage Ventures.
Shanghai Ruiang Biotechnology
Series BDeveloper of in-vitro diagnostic testing kits. The company focuses on the R&D, production, sales, and testing services of individualized molecular diagnostic reagents. The company provides accurate detection of genes and antigens for patients with hematological diseases, solid tumors, and infectious diseases. The main products are leukemia-associated fusion gene detection kit, immunoglobulin gene rearrangement…
About
Business model
Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.
Similar startups
Raising like Shanghai Ruiang Biotechnology?
Analyze your pitch deck before your next raise.
Analyze My Deck →